Reaction

Retinal Fibrosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 69 reports · 2 co-occurring drugs

As of the last recalculation, Retinal Fibrosis appears in 69 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 276.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ranibizumab18276.4276.6
Aflibercept19253.1253.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.